These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25480503)

  • 21. Treatment of urgency and urge incontinence with flavoxate in the People's Republic of China.
    Gu FL; Reng ZY; Shang GZ; Shao HX; Wang B; Cheng ZD; Jiang Y; Zhao WP; Zheng JF; Qu CT
    J Int Med Res; 1987; 15(5):312-8. PubMed ID: 3315777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy for an overactive bladder.
    Thiagamoorthy G; Cardozo L; Srikrishna S
    Womens Health (Lond); 2015 Jul; 11(4):445-8. PubMed ID: 26238677
    [No Abstract]   [Full Text] [Related]  

  • 23. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J; Robain G; Jeandel C; Mongiat Artus P; Gamé X; Fatton B; Scheiber-Nogueira MC; Vetel JM; Mares P; Petit AC; Amarenco G;
    Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of flavoxate antispasmodic activity comparative in vitro studies.
    Cazzulani P; Panzarasa R; De Stefani C; Graziani G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):189-200. PubMed ID: 4026456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity in post-intervention prolapse and urinary outcome reporting: a one-year review of the International Urogynecology Journal.
    Globerman D; Robert M
    Int Urogynecol J; 2015 Sep; 26(9):1373-8. PubMed ID: 25944659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder.
    Uckert S; Stief CG; Odenthal KP; Truss MC; Lietz B; Jonas U
    Arzneimittelforschung; 2000 May; 50(5):456-60. PubMed ID: 10858873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rociverine for nocturia in the elderly.
    Daccó L; Intrieri L
    Clin Ther; 1986; 8(2):170-4. PubMed ID: 3698063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fesoterodine for the treatment of overactive bladder.
    Tzefos M; Dolder C; Olin JL
    Ann Pharmacother; 2009 Dec; 43(12):1992-2000. PubMed ID: 19920160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence with medication and overactive bladder: an ongoing challenge.
    Wagg A
    Expert Rev Pharmacoecon Outcomes Res; 2016 Aug; 16(4):475-81. PubMed ID: 27322110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review.
    Arruda RM; Castro R; Sartori M; Girão MJ
    Curr Opin Obstet Gynecol; 2009 Oct; 21(5):412-4. PubMed ID: 19593131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D; Sand P; Zinner N; Dmochowski R;
    J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological management of common urodynamic problems.
    Milroy E
    Urol Clin North Am; 1979 Feb; 6(1):265-72. PubMed ID: 34915
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Efficacy and Tolerability of the Nicotinic Channel Modulator Dexmecamylamine in Subjects with Overactive Bladder.
    Chancellor M; Versi E; Dvergsten C; Toler S
    J Urol; 2015 Nov; 194(5):1329-35. PubMed ID: 26073872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flavoxate hydrochloride for urinary urgency after pelvic radiotherapy: comparison of 600 mg versus 1200 mg daily dosages.
    Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
    J Int Med Res; 1988; 16(1):71-4. PubMed ID: 3350206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the development of antimuscarinic agents for overactive bladder.
    Smith AL; Wein AJ
    Trends Pharmacol Sci; 2010 Oct; 31(10):470-5. PubMed ID: 20801529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle].
    Wehnert J; Sage S
    Z Urol Nephrol; 1989 May; 82(5):259-63. PubMed ID: 2665385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the success of drug treatment in urge urinary incontinence? What should be measured?
    Dede H; Dolen İ; Dede FS; Sivaslioglu AA
    Arch Gynecol Obstet; 2013 Mar; 287(3):511-8. PubMed ID: 23086134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
    Ginsberg DA; Oefelein MG; Ellsworth PI
    Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of propiverine hydrochloride on the function of the bladder in dogs].
    Kaneko S; Haruno A; Suzuki N; Kitazato K; Yamazaki Y; Nagai M; Iriki M; Tsuchiya K; Kosaka M
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):55-60. PubMed ID: 2722084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder.
    Bridgeman MB; Friia NJ; Taft C; Shah M
    Ann Pharmacother; 2013; 47(7-8):1029-38. PubMed ID: 23757386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.